Communication, collaboration and transparency between sites and sponsors mean trials start up and close out faster.
Sponsors need a data-driven way to validate assumptions and make the right decisions throughout study planning, protocol design, country/site scenario planning, and site selection. Yet feasibility assessments are repetitious and frustrating for everyone involved when the data collected are not standardized nor made available across the sponsor enterprise to be leveraged for future studies.
In this on-demand webinar, you'll learn how IQVIA Technologies (formerly DrugDev) is transforming clinical trial feasibility and site selection across the industry. Join us to see why sites are already saying they are "highly satisfied" with the Feasibility module and its tech-adoption support.
Communication, collaboration and transparency between sites and sponsors mean trials start up and close out faster.
Increase transparency, improve communications and reduce administrative burden for all clinical trial stakeholders.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.